{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T19:23:37Z","timestamp":1789154617268,"version":"build-2803163510"},"reference-count":36,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,12,1]],"date-time":"2018-12-01T00:00:00Z","timestamp":1543622400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100001711","name":"Swiss National Science Foundation","doi-asserted-by":"publisher","award":["156393"],"award-info":[{"award-number":["156393"]}],"id":[{"id":"10.13039\/501100001711","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["NE 2126\/1-1"],"award-info":[{"award-number":["NE 2126\/1-1"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuropharmacology"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1016\/j.neuropharm.2018.09.026","type":"journal-article","created":{"date-parts":[[2018,9,18]],"date-time":"2018-09-18T06:05:44Z","timestamp":1537250744000},"page":"71-78","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"special_numbering":"C","title":["TP003 is a non-selective benzodiazepine site agonist that induces anxiolysis via \u03b12GABAA receptors"],"prefix":"10.1016","volume":"143","author":[{"given":"Elena","family":"Neumann","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William T.","family":"Ralvenius","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mario A.","family":"Acu\u00f1a","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Uwe","family":"Rudolph","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6954-4629","authenticated-orcid":false,"given":"Hanns Ulrich","family":"Zeilhofer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuropharm.2018.09.026_bib1","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1038\/sj.bjp.0706056","article-title":"Anxiogenic properties of an inverse agonist selective for \u03b13 subunit-containing GABAA receptors","volume":"144","author":"Atack","year":"2005","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2018.09.026_bib2","doi-asserted-by":"crossref","first-page":"2492","DOI":"10.1038\/npp.2016.49","article-title":"A pharmacogenetic 'restriction-of-function' approach reveals evidence for anxiolytic-like actions mediated by \u03b15-containing GABAA receptors in mice","volume":"41","author":"Behlke","year":"2016","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2018.09.026_bib3","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1037\/0735-7044.105.5.653","article-title":"Ovarian endocrine status modulates the anxiolytic potency of diazepam and the efficacy of \u03b3-aminobutyric acid-benzodiazepine receptor-mediated chloride ion transport","volume":"105","author":"Bitran","year":"1991","journal-title":"Behav. Neurosci."},{"key":"10.1016\/j.neuropharm.2018.09.026_bib4","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1111\/j.1365-2826.1995.tb00744.x","article-title":"Anxiolytic effect of progesterone is mediated by the neurosteroid allopregnanolone at brain GABAA receptors","volume":"7","author":"Bitran","year":"1995","journal-title":"J. Neuroendocrinol."},{"key":"10.1016\/j.neuropharm.2018.09.026_bib5","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/S0014-2999(03)01276-7","article-title":"The mouse defense test battery: pharmacological and behavioral assays for anxiety and panic","volume":"463","author":"Blanchard","year":"2003","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2018.09.026_bib6","doi-asserted-by":"crossref","first-page":"3433","DOI":"10.1016\/j.febslet.2015.02.036","article-title":"Dual role of dopamine D2-like receptors in the mediation of conditioned and unconditioned fear","volume":"589","author":"Brandao","year":"2015","journal-title":"FEBS Lett."},{"key":"10.1016\/j.neuropharm.2018.09.026_bib7","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1152\/jn.00539.2013","article-title":"EEG-\u03b2\/\u03b3 spectral power elevation in rat: a translatable biomarker elicited by GABAA\u03b12\/3-positive allosteric modulators at nonsedating anxiolytic doses","volume":"113","author":"Christian","year":"2015","journal-title":"J. Neurophysiol."},{"key":"10.1016\/j.neuropharm.2018.09.026_bib8","doi-asserted-by":"crossref","first-page":"8980","DOI":"10.1073\/pnas.142288699","article-title":"Trace fear conditioning involves hippocampal \u03b15 GABAA receptors","volume":"99","author":"Crestani","year":"2002","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.neuropharm.2018.09.026_bib9","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1124\/mol.59.3.442","article-title":"Molecular targets for the myorelaxant action of diazepam","volume":"59","author":"Crestani","year":"2001","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.neuropharm.2018.09.026_bib10","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/j.bcp.2014.12.010","article-title":"GABAA \u03b15 subunit-containing receptors do not contribute to reversal of inflammatory-induced spinal sensitization as indicated by the unique selectivity profile of the GABAA receptor allosteric modulator NS16085","volume":"93","author":"de Lucas","year":"2015","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.neuropharm.2018.09.026_bib11","doi-asserted-by":"crossref","first-page":"10682","DOI":"10.1523\/JNEUROSCI.1166-05.2005","article-title":"Evidence for a significant role of \u03b13-containing GABAA receptors in mediating the anxiolytic effects of benzodiazepines","volume":"25","author":"Dias","year":"2005","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2018.09.026_bib12","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.1213\/ANE.0b013e3181f9c035","article-title":"Diazepam decreases action potential firing of neocortical neurons via two distinct mechanisms","volume":"111","author":"Drexler","year":"2010","journal-title":"Anesth. Analg."},{"key":"10.1016\/j.neuropharm.2018.09.026_bib13","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.14120","article-title":"Modulation of anxiety and fear via distinct intrahippocampal circuits","volume":"5","author":"Engin","year":"2016","journal-title":"Elife"},{"key":"10.1016\/j.neuropharm.2018.09.026_bib14","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1007\/s00213-010-2142-y","article-title":"Contribution of GABAA receptors containing \u03b13 subunits to the therapeutic-related and side effects of benzodiazepine-type drugs in monkeys","volume":"215","author":"Fischer","year":"2011","journal-title":"Psychopharmacology (Berlin)"},{"key":"10.1016\/j.neuropharm.2018.09.026_bib15","first-page":"32","article-title":"Functional expression of the GABAA receptor \u03b12 and \u03b13 subunits at synapses between intercalated medial paracapsular neurons of mouse amygdala","volume":"6","author":"Geracitano","year":"2012","journal-title":"Front. Neural Circ."},{"key":"10.1016\/j.neuropharm.2018.09.026_bib16","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1002\/da.20262","article-title":"Role of GABA in anxiety and depression","volume":"24","author":"Kalueff","year":"2007","journal-title":"Depress. Anxiety"},{"key":"10.1016\/j.neuropharm.2018.09.026_bib17","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/S0074-7742(01)46063-6","article-title":"Neurosteroid modulation of recombinant and synaptic GABAA receptors","volume":"46","author":"Lambert","year":"2001","journal-title":"Int. Rev. Neurobiol."},{"key":"10.1016\/j.neuropharm.2018.09.026_bib18","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1126\/science.290.5489.131","article-title":"Molecular and neuronal substrate for the selective attenuation of anxiety","volume":"290","author":"L\u00f6w","year":"2000","journal-title":"Science"},{"key":"10.1016\/j.neuropharm.2018.09.026_bib19","doi-asserted-by":"crossref","first-page":"8611","DOI":"10.1523\/JNEUROSCI.4404-11.2012","article-title":"Tonic inhibition in principal cells of the amygdala: a central role for \u03b13 subunit-containing GABAA receptors","volume":"32","author":"Marowsky","year":"2012","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2018.09.026_bib20","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1038\/75761","article-title":"Sedative but not anxiolytic properties of benzodiazepines are mediated by the GABAA receptor \u03b11 subtype","volume":"3","author":"McKernan","year":"2000","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.neuropharm.2018.09.026_bib21","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.neuropharm.2011.08.040","article-title":"The GABA system in anxiety and depression and its therapeutic potential","volume":"62","author":"M\u00f6hler","year":"2012","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2018.09.026_bib22","doi-asserted-by":"crossref","first-page":"2495","DOI":"10.1111\/j.1460-9568.2006.04775.x","article-title":"Both \u03b12 and \u03b13 GABAA receptor subtypes mediate the anxiolytic properties of benzodiazepine site ligands in the conditioned emotional response paradigm","volume":"23","author":"Morris","year":"2006","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.neuropharm.2018.09.026_bib23","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1038\/npp.2013.221","article-title":"Antihyperalgesia by \u03b12-GABAA receptors occurs via a genuine spinal action and does not involve supraspinal sites","volume":"39","author":"Paul","year":"2014","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2018.09.026_bib24","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1124\/jpet.105.096701","article-title":"Indiplon is a high-affinity positive allosteric modulator with selectivity for \u03b11 subunit-containing GABAA receptors","volume":"317","author":"Petroski","year":"2006","journal-title":"J. Pharmacol. Exp. Therapeut."},{"key":"10.1016\/j.neuropharm.2018.09.026_bib25","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/j.neuropharm.2016.07.004","article-title":"The clobazam metabolite N-desmethyl clobazam is an \u03b12 preferring benzodiazepine with an improved therapeutic window for antihyperalgesia","volume":"109","author":"Ralvenius","year":"2016","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2018.09.026_bib26","doi-asserted-by":"crossref","first-page":"6803","DOI":"10.1038\/ncomms7803","article-title":"Analgesia and unwanted benzodiazepine effects in point-mutated mice expressing only one benzodiazepine-sensitive GABAA receptor subtype","volume":"6","author":"Ralvenius","year":"2015","journal-title":"Nat. Commun."},{"key":"10.1016\/j.neuropharm.2018.09.026_bib27","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1097\/00008877-199711000-00003","article-title":"Animal models of 'anxiety': where next?","volume":"8","author":"Rodgers","year":"1997","journal-title":"Behav. Pharmacol."},{"key":"10.1016\/j.neuropharm.2018.09.026_bib36","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1038\/44579","article-title":"Benzodiazepine actions mediated by specific \u03b3-aminobutyric acidA receptor subtypes","volume":"401","author":"Rudolph","year":"1999","journal-title":"Nature"},{"key":"10.1016\/j.neuropharm.2018.09.026_bib28","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1038\/nrd3502","article-title":"Beyond classical benzodiazepines: novel therapeutic potential of GABAA receptor subtypes","volume":"10","author":"Rudolph","year":"2011","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.neuropharm.2018.09.026_bib29","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1038\/npp.2012.265","article-title":"Reinforcing effects of compounds lacking intrinsic efficacy at \u03b11 subunit-containing GABAA receptor subtypes in midazolam- but not cocaine-experienced rhesus monkeys","volume":"38","author":"Shinday","year":"2013","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2018.09.026_bib30","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.neuropharm.2012.03.001","article-title":"Benzodiazepine-induced anxiolysis and reduction of conditioned fear are mediated by distinct GABAA receptor subtypes in mice","volume":"63","author":"Smith","year":"2012","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2018.09.026_bib31","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1038\/nature08758","article-title":"Neural bases for addictive properties of benzodiazepines","volume":"463","author":"Tan","year":"2010","journal-title":"Nature"},{"key":"10.1016\/j.neuropharm.2018.09.026_bib32","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1007\/s00213-010-1895-7","article-title":"5-HT1A receptor blockade reverses GABAA receptor \u03b13 subunit-mediated anxiolytic effects on stress-induced hyperthermia","volume":"211","author":"Vinkers","year":"2010","journal-title":"Psychopharmacology (Berlin)"},{"key":"10.1016\/j.neuropharm.2018.09.026_bib33","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1038\/81800","article-title":"Benzodiazepines act on GABAA receptors via two distinct and separable mechanisms","volume":"3","author":"Walters","year":"2000","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.neuropharm.2018.09.026_bib34","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.1016\/S0021-9258(18)45961-3","article-title":"A single histidine in GABAA receptors is essential for benzodiazepine agonist binding","volume":"267","author":"Wieland","year":"1992","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.neuropharm.2018.09.026_bib35","doi-asserted-by":"crossref","first-page":"17154","DOI":"10.1073\/pnas.0508752102","article-title":"A schizophrenia-related sensorimotor deficit links \u03b13-containing GABAA receptors to a dopamine hyperfunction","volume":"102","author":"Yee","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U. S. A."}],"container-title":["Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390818306798?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390818306798?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T19:32:55Z","timestamp":1662060775000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0028390818306798"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,12]]},"references-count":36,"alternative-id":["S0028390818306798"],"URL":"https:\/\/doi.org\/10.1016\/j.neuropharm.2018.09.026","relation":{},"ISSN":["0028-3908"],"issn-type":[{"value":"0028-3908","type":"print"}],"subject":[],"published":{"date-parts":[[2018,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"TP003 is a non-selective benzodiazepine site agonist that induces anxiolysis via \u03b12GABAA receptors","name":"articletitle","label":"Article Title"},{"value":"Neuropharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuropharm.2018.09.026","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}